Purple Biotech (PPBT) Non Operating Income (2014 - 2026)
Purple Biotech (PPBT) reported Non Operating Income of -$2.2 million for Q1 2026, down 127.58% year-over-year from $7.8 million in Q1 2025, and down 1197.46% quarter-over-quarter from $197000.0 in Q4 2025.
Purple Biotech (PPBT) Non Operating Income (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Non Operating Income data on file, last reported at -$2.2 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$2.2 million, down 127.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.0 million (up 19.56% YoY), and the FY2025 annual result was -$966000.0, down 125.93% from the prior year.
- Non Operating Income eased to -$2.2 million in Q1 2026 per PPBT's latest filing, from $197000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $197000.0 in Q4 2025 and troughed at -$2.2 million in Q1 2026.
- A 5-year average of -$635000.0 and a median of -$579500.0 in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income tumbled 4392.31% in 2022, then jumped 132.78% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$558000.0 in 2022, then tumbled by 152.33% to -$1.4 million in 2023, then surged by 57.32% to -$601000.0 in 2024, then jumped by 132.78% to $197000.0 in 2025, then tumbled by 1197.46% to -$2.2 million in 2026.
- Business Quant data shows PPBT's Non Operating Income at -$2.2 million in Q1 2026, $197000.0 in Q4 2025, and -$62000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | -2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.16 Mn |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Mar 31, 2025 | -950,000.00 |
| Dec 31, 2024 | -601,000.00 |
| Sep 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -685,000.00 |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | -692,000.00 |
| Mar 31, 2023 | -219,000.00 |
| Dec 31, 2022 | -558,000.00 |
| Sep 30, 2022 | -232,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | -98,000.00 |
| Dec 31, 2019 | -522,000.00 |
| Dec 31, 2018 | -3.07 Mn |